Skip to main content

Table 2 Comparison responder (RECIST 1.1 PR at 6 week CT) and non-responder (SD or PD at 6 week CT)

From: Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis

 

Responders* (n = 27)

Non-responders+ (n = 71)

P-value×

General features

Sum of diameter CT [cm]

7.7 ± 4.6

8.4 ± 3.9

0.44

Mean PFS ± SD [days]

401 ± 211

317 ± 230

0.10

Mean OS ± SD [days]

706 ± 320

508 ± 293

0.004

Pre-therapeutic MRI

40 s rel. uptake [%]

33.7 ± 15.6

28.4 ± 17.9

0.18

Slope 0–40 s [*10]

9.4 ± 4.7

7.9 ± 4.9

0.19

70 s rel. uptake [%]

49.0 ± 17.9

35.9 ± 25.6

0.02

Slope 0–70 s [*10]

7.7 ± 2.4

5.6 ± 3.6

0.006

Max. uptake [SI]

171 ± 24

162 ± 32

0.22

AUC [SI/250 s]

4029 ± 551

3849 ± 731

0.24

Post-therapeutic MRI

40 s rel. uptake [%]

33.4 ± 12.0

25.3 ± 17.1

0.03

Slope 0–40 s [*10]

9.7 ± 3.7

7.1 ± 4.6

0.01

70 s rel. uptake [%]

47.3 ± 22.4

32.4 ± 24.1

0.007

Slope 0–70 s [*10]

7.7 ± 3.2

5.0 ± 3.3

< 0.001

Max. uptake [SI]

182 ± 22

162 ± 25

< 0.001

AUC [SI/250 s]

4264 ± 509

3814 ± 610

0.001

Difference MRI pre-MRI post therapy

Area difference MR1-MR2 [cm2]

3.1 ± 4.1

0.6 ± 2.5

< 0.001

Δ 40 s rel. uptake [%]

0.3 ± 13.3

2.7 ± 15.8

0.49

Δ Slope 0–40 s [*10]

– 0.4 ± 3.4

0.7 ± 4.2

0.24

Δ 70 s rel. uptake [%]

2.7 ± 22.1

2.7 ± 21.1

0.99

Δ Slope 0–70 s [*10]

0.0 ± 2.8

0.5 ± 3.0

0.52

Δ Max. uptake [SI]

– 9 ± 22

0 ± 20

0.05

Δ AUC [SI/250 s]

– 184 ± 370

29 ± 474

0.04

  1. Bold means P-value < 0.05 was considered to be significant
  2. ×Means ± SD tested by students t-test
  3. *Defined as RECIST 1.1 PR in first follow-up CT
  4. +Defined as RECIST 1.1 SD or PD in first follow-up CT